| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 11/12/2008 | EP1988905A2 Method and composition for treating chronic obstructive pulmonary disease |
| 11/12/2008 | EP1988904A2 Sustained-release formulation comprising a glucuronate salt of a piperazine compound and uses thereof |
| 11/12/2008 | EP1988903A2 Methods of maintaining oral health in animals using morpholine derivatives |
| 11/12/2008 | EP1988902A2 Piperazine derivatives |
| 11/12/2008 | EP1988901A2 Ceacam based antibacterial agents |
| 11/12/2008 | EP1988900A2 Pyridine, pyrimidine and pyrazine derivatives as cxcr3 receptor modulators |
| 11/12/2008 | EP1988899A2 Aripiprazole co-crystals |
| 11/12/2008 | EP1988898A2 Pharmaceutical compositions for the treatment of attention deficit hyperactivity disorder comprising flibanserin |
| 11/12/2008 | EP1988897A1 Benzimidazolone derivatives for the treatment of urinary incontinence |
| 11/12/2008 | EP1988896A2 Immune response modifier conjugates |
| 11/12/2008 | EP1988895A2 Fluoroquinolone carboxylic acid salt compositions |
| 11/12/2008 | EP1988894A1 Rapamycin derivatives for treating neuroblastoma |
| 11/12/2008 | EP1988893A2 Desloratadine-containing formulation stabilized with cyclodextrin |
| 11/12/2008 | EP1988892A2 Modulators of muscarinic receptors |
| 11/12/2008 | EP1988891A2 Compositions and methods for inducing bone growth and inhibiting bone loss |
| 11/12/2008 | EP1988890A1 High dosage of mycophenolic acid (mpa) |
| 11/12/2008 | EP1988889A2 Compositions and methods for treatment of ophthalmic diseases and disorders |
| 11/12/2008 | EP1988888A2 Use of dha and ara in the preparation of a composition for preventing or treating obesity |
| 11/12/2008 | EP1988887A2 Method and composition for the treatment of parkinson's disease |
| 11/12/2008 | EP1988886A1 Delayed release pharmaceutical oral dosage form and method of making same |
| 11/12/2008 | EP1988885A2 Combination of organic compounds |
| 11/12/2008 | EP1988884A2 Antiviral drugs for treatment of arenavirus infection |
| 11/12/2008 | EP1988883A1 Novel pharmaceutical compositions for optimizing replacement treatments and broadening the pharmacopeia for the overall treatment of addictions |
| 11/12/2008 | EP1988882A2 Prolongation of survival of an allograft by inhibiting complement activity |
| 11/12/2008 | EP1988880A2 Stable mixture of corticosteroids |
| 11/12/2008 | EP1988878A2 Sterilization of corticosteroids with reduced mass loss |
| 11/12/2008 | EP1988874A2 Pharmaceutical formulation for aerosols, comprising two or more active agents and at least one surfactant |
| 11/12/2008 | EP1988786A1 Oligosaccharide mixture |
| 11/12/2008 | EP1988779A2 Boron-containing small molecules as anti-inflammatory agents |
| 11/12/2008 | EP1988777A2 Pyrazoles for the treatment of obesity and other cns disorders |
| 11/12/2008 | EP1988776A2 Antiviral drugs for treatment of arenavirus infection |
| 11/12/2008 | EP1988772A2 Compounds for the treatment of metabolic disorders |
| 11/12/2008 | EP1912976B1 Indol-3-yl-carbonyl-piperidin-benzoimidazole derivatives as v1a receptor antagonists |
| 11/12/2008 | EP1893597B1 Ampa receptor potentiators |
| 11/12/2008 | EP1888577B1 Ocaperidone salts and pharmaceutical compositions containing the same |
| 11/12/2008 | EP1863791B1 2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl-piperidines used as cgrp antagonists |
| 11/12/2008 | EP1863474B1 Novel thiophene derivatives as sphingosine-1-phosphate-1 receptor agonists |
| 11/12/2008 | EP1844029B1 Novel heterocyclic oxime derivatives, method for preparing same and use thereof as hypoglycaemic or hypolipidemic agents |
| 11/12/2008 | EP1841768B1 Purine derivatives acting as a2a receptor agonists |
| 11/12/2008 | EP1799709A4 Myostatin isoform |
| 11/12/2008 | EP1799696B1 Phosphoindoles as hiv inhibitors |
| 11/12/2008 | EP1799202B1 Therapeutical agent useful for the treatment of plasma cell neoplasias |
| 11/12/2008 | EP1781115B1 Food supplement for livestock |
| 11/12/2008 | EP1751138B9 Indol-2-one derivatives for the treatment of central nervous disorders, gastrointestinal disorders and cardiovascular disorders |
| 11/12/2008 | EP1732918B1 Novel pyrrolidine-3,4-dicarboxamide derivatives |
| 11/12/2008 | EP1727808B1 Biaryl amino acids and their use in dna binding oligomers |
| 11/12/2008 | EP1720538B1 Method for inducing cell death with carbonyl scavengers |
| 11/12/2008 | EP1718623B1 Compounds as inhibitors of cell proliferation and viral infections |
| 11/12/2008 | EP1713813B1 Polymorphic forms of a gabaa agonist |
| 11/12/2008 | EP1708679B1 Pharmaceutical spray formulation comprising a hydro fluor alkane and an acylated cyclodextrin |
| 11/12/2008 | EP1705989B1 Substituted arylpyrazoles as parasiticidal agents |
| 11/12/2008 | EP1703905B1 Indole derivatives and use thereof as kinase inhibitors in particular ikk2 inhibitors |
| 11/12/2008 | EP1692143B1 Tricyclic indole hydroxyethylamine derivatives and their use in the treatment of alzheimer's disease |
| 11/12/2008 | EP1658067B1 Indolamide derivatives which possess glycogen phosphorylase inhibitory activity |
| 11/12/2008 | EP1651191B1 Effervescent pharmaceutical compositions containing vitamin d, calcium and phospate and their therapeutic use |
| 11/12/2008 | EP1646634B1 Use of rapamycin and rapamycin derivatives for the treatment of bone loss |
| 11/12/2008 | EP1644340B1 N-[({'4-substituted piperazine-1-yl}sulfonylmethyl)alkyl]-n-hydroxyformamide compounds as metalloproteinase inhibitors |
| 11/12/2008 | EP1641780B1 Processes for the preparation of 1- [(benzoimidazole-1yl) quinolin-8-yl] piperidin-4-ylamine derivatives |
| 11/12/2008 | EP1628977B1 ANTIBIOTIC TETRAHYDRO-b-CARBOLINE DERIVATIVES |
| 11/12/2008 | EP1624868B1 "(2-hydroxy-2-(4-hydroxy-3-hydoxymethylphenyl)-ethylamino)- propyl]phenyl derivatives as beta2 agonists |
| 11/12/2008 | EP1608346B1 Alpha-hydroxy acid ester drug delivery compositions and methods of use |
| 11/12/2008 | EP1606282B1 Phenyl- and pyridylpipereidinye-derivatives as modulators of glucose metabolism |
| 11/12/2008 | EP1587806B1 Pyrimido 5,4-e 1,2,4 triazine-5,7-diones, methods for producing the same and their use |
| 11/12/2008 | EP1587484A4 Method of treating angiogenic tissue growth |
| 11/12/2008 | EP1569627B1 Method of treating movement disorders using barbituric acid derivatives |
| 11/12/2008 | EP1549648B1 Bicyclic heteroaromatic compounds as kinase inhibitors |
| 11/12/2008 | EP1549159B1 Beverages containing plant sterols |
| 11/12/2008 | EP1534291B1 2-(phenylthiomethyl)- morpholine derivatives for use as selective norepinephrine reuptake inhibitors |
| 11/12/2008 | EP1532117B1 Multi-substituded imidazolines and method of use thereof |
| 11/12/2008 | EP1523488B1 Novel thiophenylglycoside derivatives, methods for production thereof, medicaments comprising said compounds and use thereof |
| 11/12/2008 | EP1511732B9 Process for the manufacture of quinoline derivatives |
| 11/12/2008 | EP1485338B1 Alkoxy-substituted indanones and the production thereof |
| 11/12/2008 | EP1472278B1 Macrocyclic peptides active against the hepatitis c virus |
| 11/12/2008 | EP1465912B1 Chimeric tnf ligands |
| 11/12/2008 | EP1424894B1 Inhibition of pathological angiogenesis in vivo |
| 11/12/2008 | EP1409468B1 Guanidinobenzamides as mc4-r agonists |
| 11/12/2008 | EP1365771B9 Method of treating certain eye diseases |
| 11/12/2008 | EP1343503B1 Heteroaryl urea neuropeptide y y5 receptor antagonists |
| 11/12/2008 | EP1315490B1 A method for treating allergies using substituted pyrazoles |
| 11/12/2008 | EP1261607B1 2,4-disubstituted thiazolyl derivatives |
| 11/12/2008 | EP1171114B1 Method for the treatment of incontinence |
| 11/12/2008 | EP1055426B1 Dysuria remedies |
| 11/12/2008 | EP1014969B1 Plant proanthocyanidin extract effective at inhibiting adherence of bacteria with p-type fimbriae to surfaces |
| 11/12/2008 | EP0944647B1 Submucosa extracts |
| 11/12/2008 | CN201147570Y Face mask for curing head diseases |
| 11/12/2008 | CN201147556Y Heat-sensitive surface anesthesia plaster |
| 11/12/2008 | CN201147507Y Long-acting blood pressure-reducing sustained-release degradation stick |
| 11/12/2008 | CN101305095A Inhibition of viral gene expression using small interfering RNA |
| 11/12/2008 | CN101305011A Pyridine derivatives and their use in the treatment of psychotic disorders |
| 11/12/2008 | CN101305010A Raf inhibitor compounds and methods of use thereof |
| 11/12/2008 | CN101305009A Aza-substituted spiro derivative |
| 11/12/2008 | CN101305008A Tetracyclic indole derivatives as antiviral agents |
| 11/12/2008 | CN101305007A Pyrazolo[4,3-d]pyrimidin-5-yl)derivative used as PDE5 inhibitors |
| 11/12/2008 | CN101305005A Novel diazaspiroalkanes and their use for treatment of CCR8 mediated diseases |
| 11/12/2008 | CN101305004A Novel diazabicyclic aryl derivatives and their medical use |
| 11/12/2008 | CN101305003A (1-aza-bicyclo[3.3.1] n0n-4-yl)-[5-(1H-indol-5-yl)-heteroaryl]-amines as cholinergic ligands of the n-ACHR for the treatment of psychotic and neurodegenerative disorders |
| 11/12/2008 | CN101305002A Methods of modulating neurotrophin-mediated activity |
| 11/12/2008 | CN101305001A Indolizine derivatives as ligands of the CRTH2 receptor |
| 11/12/2008 | CN101305000A 5-oxo-5,8-dihydro-pyrido-pyrimidines as inhibitors of C-FMS kinase |
| 11/12/2008 | CN101304999A Non-steroidal compounds useful as glucocorticoid receptor modulators |